abstract |
A novel antibody targeting CD19 is provided. An antibody comprising at least one modification compared to a parent antibody, wherein the modification modifies affinity for FcγR or modifies effector function compared to the parent antibody, And methods using these antibodies are disclosed. [Selection figure] None |